真皮植入物：用于软组织填充的注射产品的安全性。

Dermal implants: safety of products injected for soft tissue augmentation.

作者信息

Clark D P, Hanke C W, Swanson N A

机构信息

Division of Dermatology, University of Missouri, School of Medicine, Columbia, MO 65212.

出版信息

J Am Acad Dermatol. 1989 Nov;21(5 Pt 1):992-8. doi: 10.1016/s0190-9622(89)70288-7.

DOI:10.1016/s0190-9622(89)70288-7

PMID:2681290

Abstract

Soft tissue augmentation is a frequently performed outpatient operation. Products available for soft tissue augmentation vary in chemistry, clinical indications, and toxicity. This review examines safety and efficacy data for collagen implants (Zyderm and Zyplast), gelatin matrix implants (Fibrel), and injectable silicone. Soft tissue augmentation requires excellent technique to achieve excellent clinical efficacy. When used appropriately, the available products for soft tissue augmentation have few complications or adverse reactions.

摘要

软组织填充是一种常见的门诊手术。可用于软组织填充的产品在化学性质、临床适应症和毒性方面各不相同。本综述研究了胶原蛋白植入物（Zyderm和Zyplast）、明胶基质植入物（Fibrel）和注射用硅酮的安全性和有效性数据。软组织填充需要精湛的技术才能取得良好的临床效果。如果使用得当，现有的软组织填充产品很少会出现并发症或不良反应。